Verve Therapeutics Inc Financial Flexibility Index
Verve Therapeutics Inc financial flexibility index. Verve Therapeutics Inc (VERV) has a Financial Flexibility Index of -0.19x as of March 2025. Free cash flow of $-26.62 Million (operating CF $-27.84 Million minus capex $1.22 Million) represents 0% of total liabilities ($140.65 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Verve Therapeutics Inc (2019–2024)
Financial flexibility index of Verve Therapeutics Inc from 2019 to 2024. Historical Financial Flexibility Index trend for Verve Therapeutics Inc across 6 annual periods. Explore Verve Therapeutics Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Verve Therapeutics Inc Financial Flexibility Index by Year (2019–2024)
Verve Therapeutics Inc financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for Verve Therapeutics Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Verve Therapeutics Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.00x | $-153.96 Million | $-157.69 Million | $153.99 Million | ▼ -9.2% |
| 2023 | -0.92x | $-140.27 Million | $-149.55 Million | $153.19 Million | ▼ -7.7% |
| 2022 | -0.85x | $-109.10 Million | $-122.33 Million | $128.29 Million | ▲ +69.0% |
| 2021 | -2.75x | $-73.52 Million | $-77.88 Million | $26.77 Million | ▼ -1127.5% |
| 2020 | -0.22x | $-31.84 Million | $-35.27 Million | $142.32 Million | ▼ -65.0% |
| 2019 | -0.14x | $-5.58 Million | $-7.44 Million | $41.20 Million | — |